Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001181431-14-006597

CFO sold 16,000 shares at $18.77 ($300,290)

  • CFO acquired 16,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Myszkowski Kenneth Allen · CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2014-02-12 Exercise or conversion : show line 1 in the form +16,000 $2.01 $32,160 87,500 D
2014-02-12 Sale : show line 2 in the form −16,000 $18.77 $300,290 71,500 D
Open-market sales · 16,000 sh · avg $18.77 · $300,290

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2014-02-12 Exercise or conversion : show line 3 in the form Stock Option −16,000 312,000 D
Loading xslF345X03/rrd402396.xml…